BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 15150069)

  • 1. Prognostic factors in resected pathologic (p-) stage IIIA-N2, non-small-cell lung cancer.
    Tanaka F; Yanagihara K; Otake Y; Kawano Y; Miyahara R; Takenaka K; Katakura H; Ishikawa S; Ito H; Wada H
    Ann Surg Oncol; 2004 Jun; 11(6):612-8. PubMed ID: 15150069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer.
    Takenaka K; Ishikawa S; Yanagihara K; Miyahara R; Hasegawa S; Otake Y; Morioka Y; Takahashi C; Noda M; Ito H; Wada H; Tanaka F
    Ann Surg Oncol; 2005 Oct; 12(10):817-24. PubMed ID: 16132376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station.
    Ichinose Y; Kato H; Koike T; Tsuchiya R; Fujisawa T; Shimizu N; Watanabe Y; Mitsudomi T; Yoshimura M; Tsuboi M;
    J Thorac Cardiovasc Surg; 2001 Oct; 122(4):803-8. PubMed ID: 11581617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
    Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
    Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Impact of adjuvant therapies in a subset of patients at high risk of recurrence.
    Angeletti CA; Lucchi M; Fontanini G; Mussi A; Chella A; Ribechini A; Vignati S; Bevilacqua G
    Cancer; 1996 Aug; 78(3):409-15. PubMed ID: 8697384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic heterogeneity in multilevel N2 non-small cell lung cancer patients: importance of lymphadenopathy and occult intrapulmonary metastases.
    Sakao Y; Okumura S; Mun M; Uehara H; Ishikawa Y; Nakagawa K
    Ann Thorac Surg; 2010 Apr; 89(4):1060-3. PubMed ID: 20338307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
    Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skip mediastinal nodal metastases in non-small cell lung cancer.
    Tanaka F; Takenaka K; Oyanagi H; Fujinaga T; Otake Y; Yanagihara K; Ito H; Wada H
    Eur J Cardiothorac Surg; 2004 Jun; 25(6):1114-20. PubMed ID: 15145018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases.
    Casali C; Stefani A; Natali P; Rossi G; Morandi U
    Eur J Cardiothorac Surg; 2005 Jul; 28(1):33-8. PubMed ID: 15953734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of angiopoietins and its clinical significance in non-small cell lung cancer.
    Tanaka F; Ishikawa S; Yanagihara K; Miyahara R; Kawano Y; Li M; Otake Y; Wada H
    Cancer Res; 2002 Dec; 62(23):7124-9. PubMed ID: 12460935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in resected T3 non-small cell lung carcinoma: perineural invasion as a new prognostic factor.
    Demir A; Gunluoglu MZ; Kara HV; Buyukpinarbasili N; Dincer SI
    Thorac Cardiovasc Surg; 2008 Mar; 56(2):93-8. PubMed ID: 18278684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
    Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
    J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer.
    Chen F; Takenaka K; Ogawa E; Yanagihara K; Otake Y; Wada H; Tanaka F
    Clin Cancer Res; 2004 Dec; 10(24):8548-53. PubMed ID: 15623638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Completely resected non-small cell lung cancer: reconsidering prognostic value and significance of N2 metastases.
    Riquet M; Bagan P; Le Pimpec Barthes F; Banu E; Scotte F; Foucault C; Dujon A; Danel C
    Ann Thorac Surg; 2007 Dec; 84(6):1818-24. PubMed ID: 18036891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2?
    Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F
    Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.